DocGo (DCGO) Competitors $1.56 +0.03 (+1.96%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$1.56 +0.00 (+0.32%) As of 09/15/2025 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DCGO vs. INNV, AGL, AUNA, PSNL, TALK, SBC, EHAB, AIRS, TOI, and LFMDShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include InnovAge (INNV), Agilon Health (AGL), Auna (AUNA), Personalis (PSNL), Talkspace (TALK), SBC Medical Group (SBC), Enhabit (EHAB), AirSculpt Technologies (AIRS), Oncology Institute (TOI), and LifeMD (LFMD). These companies are all part of the "healthcare" industry. DocGo vs. Its Competitors InnovAge Agilon Health Auna Personalis Talkspace SBC Medical Group Enhabit AirSculpt Technologies Oncology Institute LifeMD InnovAge (NASDAQ:INNV) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability. Is INNV or DCGO more profitable? InnovAge has a net margin of -3.55% compared to DocGo's net margin of -4.20%. DocGo's return on equity of -3.26% beat InnovAge's return on equity.Company Net Margins Return on Equity Return on Assets InnovAge-3.55% -12.02% -5.73% DocGo -4.20%-3.26%-2.24% Do insiders & institutionals have more ownership in INNV or DCGO? 12.3% of InnovAge shares are owned by institutional investors. Comparatively, 56.4% of DocGo shares are owned by institutional investors. 1.4% of InnovAge shares are owned by insiders. Comparatively, 3.8% of DocGo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, INNV or DCGO? InnovAge has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, DocGo has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Which has better earnings & valuation, INNV or DCGO? DocGo has lower revenue, but higher earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInnovAge$853.70M0.79-$30.31M-$0.23-21.65DocGo$616.55M0.25$19.99M-$0.19-8.21 Do analysts recommend INNV or DCGO? InnovAge currently has a consensus target price of $5.00, indicating a potential upside of 0.40%. DocGo has a consensus target price of $3.59, indicating a potential upside of 130.13%. Given DocGo's stronger consensus rating and higher probable upside, analysts clearly believe DocGo is more favorable than InnovAge.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InnovAge 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50DocGo 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media refer more to INNV or DCGO? In the previous week, InnovAge had 19 more articles in the media than DocGo. MarketBeat recorded 22 mentions for InnovAge and 3 mentions for DocGo. DocGo's average media sentiment score of 1.27 beat InnovAge's score of 0.86 indicating that DocGo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 4 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive DocGo 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDocGo beats InnovAge on 12 of the 16 factors compared between the two stocks. Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$149.65M$7.56B$5.80B$10.17BDividend YieldN/A2.81%5.72%4.61%P/E Ratio-8.2174.7875.0526.39Price / Sales0.2535.79544.00190.24Price / Cash3.6224.0725.8129.91Price / Book0.508.1113.436.28Net Income$19.99M$241.92M$3.29B$270.38M7 Day Performance-1.27%-1.38%0.08%1.89%1 Month Performance-3.70%1.29%4.61%6.01%1 Year Performance-57.14%3.27%75.02%25.26% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo2.3364 of 5 stars$1.56+2.0%$3.59+130.1%-57.3%$149.65M$616.55M-8.214,407Positive NewsINNVInnovAge0.5336 of 5 stars$4.03+6.3%$5.00+24.1%-16.9%$511.70M$763.85M-17.522,350Earnings ReportAGLAgilon Health2.6903 of 5 stars$1.26+4.6%$3.07+144.7%-68.4%$497.31M$6.06B-1.631,076AUNAAuna3.6825 of 5 stars$6.35-0.2%$10.70+68.5%-13.0%$470.72M$1.17B7.2114,842PSNLPersonalis4.0107 of 5 stars$5.32+1.5%$7.42+39.4%+4.2%$464.67M$84.61M-4.16400TALKTalkspace3.9229 of 5 stars$2.67+2.3%$4.50+68.5%+30.6%$437.09M$187.59M133.57500SBCSBC Medical Group2.0924 of 5 stars$4.99+20.2%N/AN/A$431.11M$205.42M15.59N/AGap UpHigh Trading VolumeEHABEnhabit3.1681 of 5 stars$7.72-1.0%$8.67+12.3%-4.9%$394.88M$1.03B-2.8910,700Positive NewsAIRSAirSculpt Technologies0.6473 of 5 stars$6.20+5.4%$3.75-39.5%+47.1%$367.13M$180.35M-24.80240Positive NewsGap UpTOIOncology Institute2.8058 of 5 stars$3.25-1.5%$7.00+115.4%+847.8%$308.57M$393.41M-4.78660Positive NewsLFMDLifeMD3.5536 of 5 stars$6.15+1.5%$13.17+114.1%+10.6%$287.35M$212.45M-29.29230 Related Companies and Tools Related Companies INNV Alternatives AGL Alternatives AUNA Alternatives PSNL Alternatives TALK Alternatives SBC Alternatives EHAB Alternatives AIRS Alternatives TOI Alternatives LFMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DCGO) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
